These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16294633)

  • 1. Too many drugs.
    Hammerschlag C
    Caring; 2005 Sep; 24(9):76. PubMed ID: 16294633
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug misuse: a growing national problem.
    Hertz JA; Knight JR
    Adolesc Med Clin; 2006 Oct; 17(3):751-69; abstract xiii. PubMed ID: 17030290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 5. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formulary files. Use of attention-deficit medications surges 369 percent in children under 5.
    Manag Care; 2004 Jun; 13(6):48. PubMed ID: 15259443
    [No Abstract]   [Full Text] [Related]  

  • 8. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating patients with ADHD and coexisting conditions.
    Donnelly CL
    Behav Healthc; 2006 Sep; 26(9):39-51. PubMed ID: 17086843
    [No Abstract]   [Full Text] [Related]  

  • 10. ADHD drugs and cardiovascular risk.
    Rappley MD; Moore JW; Dokken D
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in medication treatment for ADHD.
    Castle L; Aubert RE; Verbrugge RR; Khalid M; Epstein RS
    J Atten Disord; 2007 May; 10(4):335-42. PubMed ID: 17449832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmedical use of prescription stimulants in the United States.
    Kroutil LA; Van Brunt DL; Herman-Stahl MA; Heller DC; Bray RM; Penne MA
    Drug Alcohol Depend; 2006 Sep; 84(2):135-43. PubMed ID: 16480836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM; Friedman RA; Knilans TK; ;
    Pediatrics; 2008 Aug; 122(2):451-3. PubMed ID: 18676566
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 16. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addictive drugs still best option for attention deficit disorder.
    Basu P
    Nat Med; 2006 Apr; 12(4):374. PubMed ID: 16598272
    [No Abstract]   [Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder and complementary/alternative medicine.
    Sawni A
    Adolesc Med State Art Rev; 2008 Aug; 19(2):313-26, xi. PubMed ID: 18822835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit hyperactivity disorder: a view from the USA.
    Riddle MA; Walkup JT
    Nat Clin Pract Neurol; 2008 Mar; 4(3):118-9. PubMed ID: 18227825
    [No Abstract]   [Full Text] [Related]  

  • 20. More young adults prescribed ADHD drugs.
    Manag Care; 2006 Jun; 15(6):60. PubMed ID: 16838887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.